Phase II trial of imatinib (Gleevec®) in patients with metastatic renal cell carcinoma

By Vuky Jacqueline   Isacson Christina   Fotoohi Mehran   Cruz Jason   Otero Henry   Picozzi Vincent   Malpass Thomas   Aboulafia David   Jacobs Andrew  

Investigational New Drugs, Vol. 24, Iss. 1, 2006-01 ,pp. : 85-88

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma

By Olencki Thomas   Malhi Sareena   Mekhail Tarek   Dreicer Robert   Elson Paul   Wood Laura   Bukowski Ronald  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

Interferon-α plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: A pilot study

By Amato Robert   Rawat Anish  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 171-175

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma

By Huie Michael   Oettel Kurt   Ummersen Lynn   Kim Kyung   Zhang Yulin   Staab Mary   Horvath Dottie   Marnocha Rebecca   Douglas Jeff   Drezen Amy   Alberti Dona   Wilding George  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of vinflunine in patients with metastatic renal cell carcinoma

By Goldstein D.   Ackland S.   Bell D.   Olver I.   Davis I.   Rosenthal M.   Toner G.   Pinel M.   Byrne M.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 429-434

Springer Publishing Company

Access to resources Recommend Favorite